# MEDIHUB

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medihub

- Industry: Medical Devices & Equipment
- Headquarters: Gunpo, South Korea
- Website: www.medihub.co.kr
- Total disclosed funding: $1.7M
- Latest round: Series A (Dec 21, 2021)
- Investors on record: 3

## About

Founded in 2017 and based in Gunpo, South Korea, MEDIHUB is a company specializing in the development of medical automatic syringes. The company conducts research and development of auto-injector syringes and developed the digital painless anesthetic i-Exec based on the pain relief algorithm PCGT or Pain Control Golden Time. The auto-injector is characterized by reducing the fear of injection by relieving the pain of anesthesia injection. In April 2023, MEDIHUB raised KRW 5 billion in venture funding from investor MediHub Medical Personnel Investment Association No. 1. As of 2023, the company is led by its CEO Yoo Hyeong-hyung. MEDIHUB offers research and development of auto-injector syringes and develops the digital painless anesthetic i-Exec based on the pain relief algorithm PCGT or Pain Control Golden Time. The company will use the April funding to expand its service by expanding corporate medical advice and activating individual medical advice applications.

## Funding rounds

- Series A, Dec 21, 2021, $1.7M — DAWON Asset Management, PGS Partners, ReInvestment

## Investors

- DAWON Asset Management — Series A
- PGS Partners — Series A
- ReInvestment (https://capitalatlas.ai/funds/reinvestment) — Series A